Content & Phases

Positioning, Data Analysis, Market Access Strategy or Training & Education and first EU Importer

Here you will find the content and phases - how do we develop your strategy

Marked location analysis

Start-UP

Contents

Determining on the position of your medical product is a qualified analysis that shows exactly where your product currently stands in the market or which points still need to be worked out.

e.g.
Do I have the right pioneers, do I have meaningful studies and is the indication effective?

Does the product have sufficient acceptance, is reimbursement regulated, in which sector do I find my potential, outpatient, inpatient, private or specialist?

How is sales is structured, in which sector can I use it? Have appropriate marketing materials been prepared and?

Phases

Story & Pioneers
Story
Studies
Pioneers
Indication
Acceptance

Payers & Stakeholders
Payers
Patients
Societies
Potential
Stakeholders

Sectors & Sales
Sales
Sectors
Marketing
Refund
Competition

Data analysis

Start-UP

Contents

Data analyzes are an important tool to support your story with data based on facts.

Various data, med. Studies and cost studies are combined to clear Cost Models.

These cost models not only help users, they also convince controllers and buyers. 

The cost models allow sales to find and convince new contacts. In the medium term, as part of market access, it will be possible to collect data for an application for additional remuneration; The InEK can check the data via its calculation houses.

Cost models allow your Sales-team to sell the product in a new way on health-economic background.  

Phases

Data
§21 Data set from the hospital
ICD & OPS overviews
DRG numbers for hospital billing
InEK cost data
AOP outpatient surgery in the hospital (§115)
EBM outpatient billing contract doctor
GOÄ numbers for private billing (PKV)
Cross-sector Hybrid DRGs

Evidence and studies
Cost analysis (not comparative)
Cost comparison analysis (comparative)
Cost-benefit analysis (comparative)


Cost models
Model (comparative model)



Market access strategy

Start-UP

Contents

The market access strategy comes after the location analysis and fills in the open points. If important strategy points or stakeholders are missing, progress is often not possible.

The market access strategy the path and the timeline. Many of the projects can be implemented in the short term, but there are also projects that are medium and long-term and require time.

Particularly in the case of cost studies for additional compensation (ZE), 1-3 years (depending on the number of cases) may be necessary to generate the data.

To bridge the time, you can, for example, use individual applications or try to establish other strategies.


Phases

Story & Pioneers
Story
Pioneers
Studies
Indication
Acceptance

Payers & stakeholders
Payers
Potential
Societies
Patients
Stakeholders
Sectors & Sales
Distribution
Sectors
Marketing
Refund
Competition



Training & Education

Start-UP

Contents

If you do not want to use a location analysis, a market access strategy or data & facts, but would like to learn these skills by you yourself, we also offer you our knowledge in training courses and/or trainings on the Job. If you are interested, move to


We offer  SIX modules:
  1. Health systems in the EU
  2. Basics of health economics
  3. Institutions
  4. Market Access
  5. Special
  6. Sales

Our trainers are long-time experts in each field and are always looking forward to working with our customers.

Phases

Health systems in the EU
Germany, Switzerland, Austria,Spain, England, France, Nordic, ...

Basics of health economics
Introduction, studies, professional societies, users, payers, patients

Institutions
GBA, InEK, BfArM, AWMF, IQTIG

Market Access
Positioning, sectors, potential, cost models, reimbursement, coding guidelines, competition

Special
NUB, ICD, OPS, DRG-Split, ZE, Studies, HTA, IV-Contract, individual application, ect.

Sales
Training the story, stakeholders, potential, studies, guidelines, models, controlling

EU First-Importer

Start-UP
Start-UP

Inhalt

If your product has CE, we will also help you import the goods into the EU, as the first EU importer, in order to comply with all regulations.

Herewith we work together with our primary First-Importer BSB-Medical:

We have prepared 6 modules:
  1. Reporting System
  2. Certifications
  3. Vigilance
  4. Warehouse
  5. Customs
  6. Sales
With experience from the US and Japan, you are in good hands with us. Reporting, certification, vigilance system, customs/warehouse, and sales, all from a single source.

You get access to all systems to enable optimal and transparent control at optimal costs.

Phasen

Reporting System
We offer you an online platform for customs, training certificates, a Vigelanz system, training and warehousing.

Certifications
Certification of all users for complete documentation.

Vigelanz
Use of an optimal Vigelanz system and a database of incidents.

Warehouse
We set up our warehouse according to your needs including 48h delivery service.

Customs
Customs clearance and transfer, as well as the completion of all formalities

Sales
Setting up and training a sales team with optimal potential

Investment

What do you have to invest?
Much of the information listed above will help you and bring you a little closer to your goal.

However, everything takes time because the GBA regulations have become very complex, especially when it comes to medical devices with high risk classes 2b or 3.

You need perseverance and resources to finance this.
  • We'll tell you what it costs
  • We tell you what is possible
  • We'll tell you how long it takes